Suppr超能文献

感染性并发症对腹膜透析患者生存的影响。

Effects of infectious complications on patients' survival in peritoneal dialysis.

机构信息

Clinic of Nephrology, Sisli Etfal Research and Educational Hospital, Istanbul, Turkey.

出版信息

Eur Rev Med Pharmacol Sci. 2013 Apr;17(8):1064-72.

Abstract

AIM

To investigate the impacts of infectious complications on mortality and morbidity; and to identify the other potential factors effective in mortality in peritoneal dialysis (PD) patients.

PATIENTS AND METHODS

We included patients who initiated therapy between 2001-2011. Patients were divided into two groups regarding to presence or absence of infectious complications. Socio-demographic data and clinical courses were compared and the reasons for PD withdrawal were obtained. Survival analysis of all patients was performed and the effects of infectious complications on mortality were investigated.

RESULTS

301 patients were included in this retrospective study. 214 patients (mean follow-up time 28.7±16.5 months) had infection history, 87 patients (mean follow-up time 48.9±29.6 months) had no infection history. There were no statistically significant difference in comparison of the groups in terms age, gender, education levels, hemodialysis history. In patients with infection history, 465 peritonitis and 213 catheter exit site infection attacks were diagnosed. The most frequently agent was methicillin-sensitive Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus in both conditions, while 25% of catheter exit site infection and 25% of peritonitis attacks were culture negative. During follow-up period, 60 patients transferred to hemodialysis, 58 patients died, 18 patients had renal transplantation in patients with infection history. In other group, 27 patients died, 23 patients had renal transplantation and 11 patients transferred to hemodialysis. Mean survival times were 56.3±2.8 months in patients with infection history and 86.8±6.1 months in other group. Mortality rate was found higher in patients with infection history (long-rank: 0.030). PD preference (OR: 5.213, p < 0.001), pretreatment low serum albumin (OR: 0.378, p = 0.001), low hemoglobin levels (OR: 0.810, p = 0.029) were found as predictors of survival in patients with infection history.

CONCLUSIONS

Infectious complications have negative effects on patient survival. Nature of PD preference, initial hypoalbuminemia and anemia were found to increase the mortality rate. The major causes of deaths were peritonitis and/or sepsis in patients with infectious complications, while the major cause of death was cardiac reasons in patients without infectious complications.

摘要

目的

探讨感染并发症对腹膜透析(PD)患者死亡率和发病率的影响,并确定其他可能影响死亡率的因素。

方法

我们纳入了 2001 年至 2011 年间开始治疗的患者。根据是否存在感染并发症将患者分为两组。比较了两组患者的社会人口统计学数据和临床经过,并获得了 PD 退出的原因。对所有患者进行生存分析,并研究感染并发症对死亡率的影响。

结果

本回顾性研究纳入了 301 例患者。214 例(平均随访时间 28.7±16.5 个月)有感染史,87 例(平均随访时间 48.9±29.6 个月)无感染史。两组患者在年龄、性别、教育程度、血液透析史方面无统计学差异。在有感染史的患者中,诊断出 465 例腹膜炎和 213 例导管出口部位感染。两种情况下最常见的病原体均为甲氧西林敏感金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌,而 25%的导管出口部位感染和 25%的腹膜炎发作培养结果为阴性。在随访期间,有 60 例患者转为血液透析,58 例患者死亡,18 例患者在有感染史的患者中进行了肾移植。在另一组中,27 例患者死亡,23 例患者进行了肾移植,11 例患者转为血液透析。有感染史的患者平均生存时间为 56.3±2.8 个月,无感染史的患者为 86.8±6.1 个月。有感染史的患者死亡率较高(秩和检验:0.030)。有感染史的患者中,PD 偏好(OR:5.213,p < 0.001)、治疗前低血清白蛋白(OR:0.378,p = 0.001)、低血红蛋白水平(OR:0.810,p = 0.029)是生存的预测因素。

结论

感染并发症对患者的生存有负面影响。PD 偏好、初始低白蛋白血症和贫血的性质被发现会增加死亡率。有感染并发症的患者死亡的主要原因是腹膜炎和/或败血症,而无感染并发症的患者死亡的主要原因是心脏原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验